Trademark Overview
On Monday, May 18, 2026, a trademark application was filed for SYNAPTIQ with the United States Patent and Trademark Office. The USPTO has given the SYNAPTIQ trademark a serial number of 99828827. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 18, 2026. This trademark is owned by Synaptiq Neurotech, Inc.. The SYNAPTIQ trademark is filed in the Medical Instrument Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Business consultation in the field of and for healthcare and neurotechnology
companies; business management
consulting services in the field of
psychiatric practice operations;
business development consulting for
neuromodulation and brain
stimulation technology companies
Research and development and consultation related thereto in the field of neuroscience technology; software as a
service (SaaS) featuring medical AI
software for neuroimaging analysis
and neuromodulation targeting;
non-downloadable software for brain
stimulation targeting, treatment
planning, and neurological data
analysis; medical technology research
and development services in the field
of neuromodulation
Medical services in the field of psychiatry; administration of transcranial magnetic stimulation (TMS) for the treatment of neurological and psychiatric conditions; administration of ketamine therapy for the treatment of depression and mental health disorders; medical treatment services in the field of interventional psychiatry
Transcranial magnetic stimulation apparatus for the treatment of central nervous system disorders
